Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Thyroid cancer (TC) is the most common endocrine malignancy with a rising incidence. It has a wide spectrum of clinical behavior and varied therapeutic responsiveness. Among the various forms of TC, papillary thyroid cancer (PTC) accounts for 85% of all TCs. It is the most common form compared to follicular carcinoma (FCA) and other rare forms such as medullary carcinoma (MCA), anaplastic carcinoma (ANA), poorly differentiated carcinoma (PDTC), undifferentiated thyroid carcinoma (UDTC), Hurthle cell carcinoma (HCA) and Insular carcinoma (Ins).
Htwe TT (2012) Role of Galectin-3 in Thyroid Cancer. Thyroid Disorders Ther 1:e103.
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi